TabletAnti Diabetic
Sitagliptin + Metformin Hydrochloride + Glimepiride · DPP-4 inhibitor, biguanide and sulfonylurea combination
A tablet combining sitagliptin, metformin and glimepiride, three antidiabetic agents with complementary actions. It is used in adults with type 2 diabetes mellitus whose glucose levels are not controlled by fewer agents.
Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.
01Specification
02Related